ATG5 has a key role in autophagic vesicles and has been directly implicated in immunomodulatory effects in the course of other viral infections (Jounai et al, 2007), and its upregulation was consistent from immediately after therapy began (Table 1). The gene discussed is ATG5; the disease is viral infectious disease.